Tesla enters the final week of June with a notable reversal in the short book — the positions that had been building steadily since April are now being cut, even as the stock posts its worst week in over a month.
The most striking data point this week is what shorts are not doing. Despite Tesla falling 5.7% to $381.61 — its sharpest weekly decline since the JPMorgan-upgrade rally in early June — short interest has actually dropped. SI fell to 2.29% of the free float, down from the 2.93% three-month high flagged in last week's note. That reversal is meaningful: the multi-week build that had been running since April's tariff-shock lows has unwound in a matter of days. Cost to borrow has also eased, dropping roughly 22% on the week to 0.36%. The borrow market remains exceptionally loose, with availability at its maximum reported reading — there is no squeeze pressure, no friction, no signal from the lending market that bears are pressing a crowded position.
Options positioning tells a similarly unmoved story. The put/call ratio is running at 0.74, barely above its 20-day average of 0.73 and well within one standard deviation of the mean. The PCR z-score of 0.77 points to a market that is neither defensively positioned nor exuberantly bullish. For context, the PCR 52-week high sits at 1.03 and the low at 0.68 — the current reading is squarely in the middle. In a week where the stock lost nearly $20, options traders showed no urgency to hedge.
The Street remains constructive but divided. The most significant recent analyst action was JP Morgan's June 5 upgrade from Underweight to Neutral, with a target raised to $475 from $145 — a dramatic directional shift from one of the sector's most influential houses. Bulls cluster around targets of $490–$600 (TD Cowen, Wedbush, Cantor Fitzgerald), citing Tesla's vertically integrated autonomy stack and energy storage business as underappreciated. Bears point to the valuation: a trailing P/E above 176x, EV/EBITDA near 85x, and a price-to-book close to 15x leave little margin for error if deliveries disappoint. The mean analyst target of $421 sits about 10% above the current price — a gap that has compressed considerably as the stock has retreated from its recent high near $450. Factor scores reflect the tension: the analyst recommendation divergence score ranks in the 93rd percentile, a sign of unusually wide disagreement across the Street.
On the insider front, the dominant story remains Elon Musk's June 16 sale of 17.5 million shares for roughly $7.1 billion. The trade, representing just under 1% of the company, drove 90-day net insider sales to $7.1 billion — the largest net-sell figure in the observable window. CEO selling at scale, into a stock that has since dropped further, is the defining ownership event of the past month. Institutional holders are broadly stable: BlackRock and State Street added modestly in their most recent filings, while the passive index holders reflect normal rebalancing flows.
Q2 earnings land on July 22. After the April print saw the stock fall 3.3% on the day and 3.5% over the following week, the question heading into that release is whether the short-selling community's decision to reduce exposure into this week's decline reflects genuine conviction that the worst is priced in — or simply profit-taking ahead of a catalyst that, based on recent history, has not rewarded either bulls or bears with clean momentum.
See the live data behind this article on ORTEX.
Open TSLA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
